Vol. 48, No. 1, 2022
Supramolecular Systems Based on Macrocyclic Compounds with Proteins: Application Prospects
p. 1 abstract
Heterocyclic Resveratrol Analogs: Synthesis and Physiological Activity. Part 2: Analogs Obtained by the Replacement of Ethylene Fragments with Heterocyclic Residues
p. 27 abstract
Mannose Receptors of Alveolar Macrophages as a Target for the Addressed Delivery of Medicines to the Lungs
p. 46 abstract
Lehninger’s Scheme and Conclusions Need to Be Defined More Exactly
p. 76 abstract
Direct Conjugation of Penicillins and Cephalosporins with Proteins for Receptor Assays of Beta-Lactam Antibiotics
p. 85 abstract
Effects of Cortisol and Tetrahydrocortisol on the Secondary Structure of Apolipoprotein A-I as Measured by Fourier Transform Infrared Spectroscopy
p. 96 abstract
Conjugates of Aminopenicillins with Proteins: Synthesis, Immunogenic Properties, and Binding to the β-Lactam Receptor and Antibodies
p. 105 abstract
Analogue Based Design, Synthesis, Biological Evaluation, and Molecular Docking of Some Thalidomide Metabolites as Selective Cytotoxic and Antiangiogenic Agents against Multiple Myeloma
p. 115 abstract
Synthesis, Neurotropic Activity, and Molecular Docking of New Condensed Thieno[2,3-b]pyridine Derivatives
p. 125 abstract
An Efficacious Protocol for the Reduction of Benzothiazole Using Mg/MeOH and Their Antinemic Activity against Meloidogyne incognita
p. 135 abstract
Synthesis, Structural Characterization, and Biological Evaluation of Some Hydrazone Compounds as Potential Antioxidant Agents
p. 143 abstract
Design, Synthesis of New Pyrazolo[3,4-d]Pyrimidine Derivatives and In Vitro Evaluation of Antiproliferative Activity against Leukemia Cell Lines
p. 153 abstract
Effect of Methyl-β-Cyclodextrin on the Interaction of Fluoroquinolones with Human Serum Albumin
p. 163 abstract
Hepatitis C Virus RF1_2k/1b Chimeras and a “Many Probes/One Spot” Approach to Their Identification
p. 173 abstract
Changes in the Metabolism of Sphingomyelin and Ceramide in the Brain Structures and Spinal Cord of Transgenic Mice (FUS(1-359)) Modeling Amyotrophic Lateral Sclerosis
p. 178 abstract